Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Fig. 2

Observed geometric mean changes of autoantibody responses at 12 months after baseline. The graph indicates the observed geometric mean changes (with 95% confidence intervals) of autoantibody levels against 11 tumor-associated antigens according to treatment regimen. Changes were calculated between baseline (before start of treatment) and 12 months after the start of treatment. * indicates p-value < 0.05. There were no significant changes observed for surgery only or individual therapies, including hormonal, radiation or chemotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us